Company profilePharmaceutical#397 of 1,318 in Pakistan✓ No DRAP alerts

GALLOP WATER SCIENCES

Pharmaceutical company · 42 brands · 32 molecules

Ranked #10 of 10 companies in Anaesthetic, Local

42 registered products 30 pharmaceutical brands 32 distinct molecules 0 DRAP alerts

Company overview

42
registered products
30
pharmaceutical brands
32
distinct molecules
1
therapeutic classes
0
DRAP alerts

GALLOP WATER SCIENCES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 42 product registrations across 32 distinct molecules. Its portfolio is concentrated in Anaesthetic, Local. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by GALLOP

19 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Solutions For Parenteral Nutrition 1
Solutions Affecting The Electrolyte Balance 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

13
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202513

Top molecules by brand count

Lignocaine2 brands
Sodium Chloride ...... 0.60 Gm2 brands
Mannitol1 brand
Levofloxacin .........................500Mg1 brand
Metronidazole ...... 500 Mg1 brand
Sodium Bicarbonate ...... 8.4 Gm1 brand

Therapeutic classes

Anaesthetic, Local · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official49 products · Rs 19.68 – Rs 2,797.97
Median across source: Rs 161.33

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NEUTRO PHARMA (PVT) LTD. holds 119 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
FRONTIER DEXTROSE LIMITED holds 12 molecules not in this portfolio
ChlorideDextrose 4.3%GlucoseOfloxacinOrsPotassium Chlori
Medipak (Pvt) Ltd holds 74 molecules not in this portfolio
000 I.UAdenosine Containing Eye PrepsAdernaline 1MgAminoacid PrepsAprepitantAscorbic Acid

Get the full profile for GALLOP

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.